Explore more publications!

Press Releases

ThinkCareBelieve:  Week 50 America’s New Year in the Trump 2.0 Administration
Larry W. Foy, Sr. Launches Campaign for Louisiana’s 5th District in the United States Congress
Aging Industrial Infrastructure Raises Safety Concerns as Welding Inspections Spike 41% Across U.S. Facilities
Best Survival Food Kit For Emergency: 4Patriots 3-Month Supply Examined as January 2026 Preparedness Surge Drives 25-Year Shelf Life, Caloric Adequacy, and Storage Condition Analysis
Outlook Therapeutics Provides Regulatory Update on U.S. Food and Drug Administration Review of ONS-5010/LYTENAVA™ (bevacizumab-vikg) for the Treatment of Wet AMD
Honoring Muslim American Heritage Month

Honoring Muslim American Heritage Month

FibroBiologics Files IND Application with the U.S. FDA to Advance Clinical Development of CYPS317 in Patients with Psoriasis
Ultragenyx Completes Rolling Submission of Biologics License Application (BLA) to U.S. FDA for DTX401 AAV Gene Therapy for Glycogen Storage Disease Type Ia (GSDIa)
Commissioner Miller Celebrates U.S. Shrinking Inflation and Agricultural Trade Deficit

Commissioner Miller Celebrates U.S. Shrinking Inflation and Agricultural Trade Deficit

Commissioner Miller Celebrates U.S. Shrinking Inflation and Agricultural Trade Deficit

Commissioner Miller Celebrates U.S. Shrinking Inflation and Agricultural Trade Deficit

Brazil's Economy Resists U.S. Tariffs

Brazil's Economy Resists U.S. Tariffs

American Center for Cures and BlueCloudX® Collaborate to Accelerate Cures and Modernize Healthcare and Clinical Research
Food & Beverage Magazine Names Metafoodx an Editor’s Top Pick for 2025
Prime Drink Group Announces First Closing of Private Placement and Grant of Stock Options
ICEPLOSION Unveils the World’s First At-Home Frozen Carbonated Slushie Machine at CES 2026
H-2B Cap Relief Essential to Sustaining America’s Seasonal Workforce and Local Economies
Axsome Therapeutics Announces FDA Acceptance and Priority Review of Supplemental New Drug Application for AXS-05 for the Treatment of Alzheimer’s Disease Agitation
U.S. FDA Approves Agios’ AQVESME™ (mitapivat) for the Treatment of Anemia in Adults with Alpha- or Beta-Thalassemia
2026 American Innovation $1 Coin Rolls and Bags™ Featuring Iowa Available on January 6
Avalon GloboCare Board Director Highlights RPM Interactive’s Automated Generative AI Video Creation Platform in Interview with ProactiveInvestors.com

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions